CDC data show cancer deaths declining as lung cancer treatment and detection advance, with new KRAS-targeted therapies showing early promise.
|Articles|June 25, 2012
Health-Law Guessing Game Grips the Capital
Advertisement
Richard Mourdock, the Republican Senate hopeful from Indiana, didn't want to be caught flat-footed when the Supreme Court announced its highly anticipated decision on the fate of the health overhaul law.
So he taped one-minute videos responding to four different scenarios: the court upholds the law; it knocks down part of the law; it invalidates the entire law; or it declines to rule on the case's merits.
Read the full story:
Source: The Wall Street Journal
Advertisement
Related to this article
Nonadherence to semaglutide for obesity worsened once out-of-pocket costs passed roughly $75 per 30-day supply among commercially insured adults.
All 50 states have applied for CMS's GENEROUS Model, a Medicaid drug pricing program expected to save $64.3 billion over the next decade.
Diabetes care improves when support adapts to real-life changes, removing barriers and sustaining daily habits beyond reminders, education, and one-time interventions.
Imlunestrant plus abemaciclib doubled median PFS in patients with ESR1-mutated advanced breast cancer.
Logistic regression beats machine learning to predict autoimmune hepatitis recurrence after liver transplantation.
A new blood test for adults as young as 40 years arrives as employers and insurers still treat Alzheimer disease as an old-age condition.
Itch and skin appearance outranked safety for 300 US adults with chronic hand eczema, but cancer risk came next.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Treatment for Sanfilippo Syndrome Type A
2
Real-World Data: FACT vs Non-FACT CAR T Outcomes Compared
3
World Alzheimer Day: Young-Onset Alzheimer Disease Often Misdiagnosed
4
FDA Approves Imlunestrant Plus Abemaciclib for Breast Cancer
5